These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 6286773

  • 1. Specific binding of phospholipid platelet-activating factor by human platelets.
    Valone FH, Coles E, Reinhold VR, Goetzl EJ.
    J Immunol; 1982 Oct; 129(4):1637-41. PubMed ID: 6286773
    [Abstract] [Full Text] [Related]

  • 2. Modulation of cytoplasmic calcium in human platelets by the phospholipid platelet-activating factor 1-O-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine.
    Valone FH, Johnson B.
    J Immunol; 1985 Feb; 134(2):1120-4. PubMed ID: 2578151
    [Abstract] [Full Text] [Related]

  • 3. Specific binding by human polymorphonuclear leucocytes of the immunological mediator 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine.
    Valone FH, Goetzl EJ.
    Immunology; 1983 Jan; 48(1):141-9. PubMed ID: 6848449
    [Abstract] [Full Text] [Related]

  • 4. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L, Floch A, Mondot S, Cavero I.
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [Abstract] [Full Text] [Related]

  • 5. Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).
    Shaw JO, Pinckard RN, Ferrigni KS, McManus LM, Hanahan DJ.
    J Immunol; 1981 Sep; 127(3):1250-5. PubMed ID: 6267133
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Decay of the activating signal after platelet stimulation with 1-0-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine: changes in calcium permeability.
    Valone FH, Johnson B.
    Thromb Res; 1985 Nov 01; 40(3):385-92. PubMed ID: 4082115
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC, Seldon PM, Barnes PJ, Giembycz MA.
    Mol Pharmacol; 1993 Feb 01; 43(2):302-12. PubMed ID: 8381515
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alkyl-ether phosphoglycerides influence calcium fluxes into human endothelial cells.
    Bussolino F, Aglietta M, Sanavio F, Stacchini A, Lauri D, Camussi G.
    J Immunol; 1985 Oct 01; 135(4):2748-53. PubMed ID: 2411812
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (AGEPC)-induced protein phosphorylation in rabbit platelets: inhibitory effects of AGEPC analogs.
    Sugatani J, Hanahan DJ.
    Arch Biochem Biophys; 1986 May 01; 246(2):855-64. PubMed ID: 3754710
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.